Skip to Main Content (Press Enter)

Logo UNIMORE
  • ×
  • Home
  • Degree programmes
  • Modules
  • Jobs
  • People
  • Research Outputs
  • Academic units
  • Third Mission
  • Projects
  • Skills

UNI-FIND
Logo UNIMORE

|

UNI-FIND

unimore.it
  • ×
  • Home
  • Degree programmes
  • Modules
  • Jobs
  • People
  • Research Outputs
  • Academic units
  • Third Mission
  • Projects
  • Skills
  1. Research Outputs

Small molecule inhibitors of BRAF in clinical trials

Academic Article
Publication Date:
2012
Short description:
Small molecule inhibitors of BRAF in clinical trials / Zambon, Alfonso; Niculescu Duvaz, Ion; Niculescu Duvaz, Dan; Marais, Richard; Springer, Caroline J.. - In: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. - ISSN 0960-894X. - 22:2(2012), pp. 789-792. [10.1016/j.bmcl.2011.11.060]
abstract:
Over the last few years, BRAF has emerged as a validated target in melanoma. This review summarises recent advances in the development of BRAF inhibitors, focussing on agents that have been assessed clinically. © 2011 Elsevier Ltd. All rights reserved.
Iris type:
Articolo su rivista
Keywords:
BRAF protein; Clinical candidate; Kinase inhibitor; Humans; Melanoma; Molecular Weight; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Structure-Activity Relationship; Clinical Trials as Topic; 3003; Drug Discovery3003 Pharmaceutical Science; Organic Chemistry; Molecular Medicine; Molecular Biology; Clinical Biochemistry; Biochemistry
List of contributors:
Zambon, Alfonso; Niculescu Duvaz, Ion; Niculescu Duvaz, Dan; Marais, Richard; Springer, Caroline J.
Authors of the University:
ZAMBON Alfonso
Handle:
https://iris.unimore.it/handle/11380/1138841
Published in:
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Journal
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.4.5.0